Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

Alexander Drilon, Salvatore Siena, Rafal Dziadziuszko, Fabrice Barlesi, Matthew G. Krebs, Alice T. Shaw, Filippo de Braud, Christian Rolfo, Myung Ju Ahn, Jürgen Wolf, Takashi Seto, Byoung Chul Cho, Manish R. Patel, Chao Hua Chiu, Thomas John, Koichi Goto, Christos S. Karapetis, Hendrick Tobias Arkenau, Sang We Kim, Yuichiro OheYu Chung Li, Young K. Chae, Christine H. Chung, Gregory A. Otterson, Haruyasu Murakami, Chia Chi Lin, Daniel S.W. Tan, Hans Prenen, Todd Riehl, Edna Chow-Maneval, Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R. Wilson, Robert C. Doebele

Research output: Contribution to journal › Article › peer-review

316 Scopus citations

Fingerprint

Dive into the research topics of 'Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials'. Together they form a unique fingerprint.

Medicine & Life Sciences